At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 2, 2026 at 16:08 ET
Two EVPs at Royalty Pharma sold a combined $6.01M in open-market sales over a one-week window, representing just 0.02% of the company's $32.1B market cap. The dollar amount is trivial relative to company size, and no CEO/CFO selling is present, making this routine insider activity with no material signal.
- EVP & Chairman Hite Christopher sold 97,400 shares for $5.51M on June 30, 2026
- EVP Urist Marshall sold 9,100 shares for $502K on June 24, 2026
- Total insider sales of $6.01M represent 0.02% of RPRX's $32.1B market cap
- Director Bonnie Bassler received a non-cash grant of 689 shares
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access